Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-07-05

Clinical Trial Update: Hormone Replacement for Premature Ovarian Insufficiency [Phase 3]

View source ↗

Summary

Phase 3 trial for hormone replacement in primary ovarian insufficiency was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pennsylvania | Conditions: Primary Ovarian Insufficiency | Phase 3 | Status: WITHDRAWN